FDA Approves Linezolid in Sodium Chloride 0.9% for Hospira
The FDA has approved Linezolid in Sodium Chloride 0.9% in a plastic container under NDA206473.
Therapeutic Area
Therapeutic area intelligence for Antibiotic with 6 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.